90 related articles for article (PubMed ID: 18467125)
1. Defining the minimal interacting regions of the tight junction protein MAGI-1 and HPV16 E6 oncoprotein for solution structure studies.
Charbonnier S; Stier G; Orfanoudakis G; Kieffer B; Atkinson RA; Travé G
Protein Expr Purif; 2008 Jul; 60(1):64-73. PubMed ID: 18467125
[TBL] [Abstract][Full Text] [Related]
2. Surface plasmon resonance analysis of the binding of high-risk mucosal HPV E6 oncoproteins to the PDZ1 domain of the tight junction protein MAGI-1.
Fournane S; Charbonnier S; Chapelle A; Kieffer B; Orfanoudakis G; Travé G; Masson M; Nominé Y
J Mol Recognit; 2011; 24(4):511-23. PubMed ID: 20842623
[TBL] [Abstract][Full Text] [Related]
3. The structural and dynamic response of MAGI-1 PDZ1 with noncanonical domain boundaries to the binding of human papillomavirus E6.
Charbonnier S; Nominé Y; Ramírez J; Luck K; Chapelle A; Stote RH; Travé G; Kieffer B; Atkinson RA
J Mol Biol; 2011 Mar; 406(5):745-63. PubMed ID: 21238461
[TBL] [Abstract][Full Text] [Related]
4. Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis.
Kranjec C; Massimi P; Banks L
J Virol; 2014 Jul; 88(13):7155-69. PubMed ID: 24696483
[TBL] [Abstract][Full Text] [Related]
5. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.
Zhang Y; Dasgupta J; Ma RZ; Banks L; Thomas M; Chen XS
J Virol; 2007 Apr; 81(7):3618-26. PubMed ID: 17267502
[TBL] [Abstract][Full Text] [Related]
6. A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions.
Kranjec C; Banks L
J Virol; 2011 Feb; 85(4):1757-64. PubMed ID: 21123374
[TBL] [Abstract][Full Text] [Related]
7. Molecular insights into the interaction of HPV-16 E6 variants against MAGI-1 PDZ1 domain.
Araujo-Arcos LE; Montaño S; Bello-Rios C; Garibay-Cerdenares OL; Leyva-Vázquez MA; Illades-Aguiar B
Sci Rep; 2022 Feb; 12(1):1898. PubMed ID: 35115618
[TBL] [Abstract][Full Text] [Related]
8. Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates.
Thomas M; Dasgupta J; Zhang Y; Chen X; Banks L
Virology; 2008 Jul; 376(2):371-8. PubMed ID: 18452965
[TBL] [Abstract][Full Text] [Related]
9. Disorder-to-order transition of MAGI-1 PDZ1 C-terminal extension upon peptide binding: thermodynamic and dynamic insights.
Ramírez J; Recht R; Charbonnier S; Ennifar E; Atkinson RA; Travé G; Nominé Y; Kieffer B
Biochemistry; 2015 Feb; 54(6):1327-37. PubMed ID: 25590897
[TBL] [Abstract][Full Text] [Related]
10. Production of functional, stable, unmutated recombinant human papillomavirus E6 oncoprotein: implications for HPV-tumor diagnosis and therapy.
Illiano E; Demurtas OC; Massa S; Di Bonito P; Consalvi V; Chiaraluce R; Zanotto C; De Giuli Morghen C; Radaelli A; Venuti A; Franconi R
J Transl Med; 2016 Jul; 14(1):224. PubMed ID: 27465494
[TBL] [Abstract][Full Text] [Related]
11. Comparison of p53 and the PDZ domain containing protein MAGI-3 regulation by the E6 protein from high-risk human papillomaviruses.
Ainsworth J; Thomas M; Banks L; Coutlee F; Matlashewski G
Virol J; 2008 Jun; 5():67. PubMed ID: 18518978
[TBL] [Abstract][Full Text] [Related]
12. 1H and 15N resonance assignment, secondary structure and dynamic behaviour of the C-terminal domain of human papillomavirus oncoprotein E6.
Nominé Y; Charbonnier S; Miguet L; Potier N; Van Dorsselaer A; Atkinson RA; Travé G; Kieffer B
J Biomol NMR; 2005 Feb; 31(2):129-41. PubMed ID: 15772752
[TBL] [Abstract][Full Text] [Related]
13. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation.
Thomas M; Glaunsinger B; Pim D; Javier R; Banks L
Oncogene; 2001 Sep; 20(39):5431-9. PubMed ID: 11571640
[TBL] [Abstract][Full Text] [Related]
14. Peptide-Protein Binding Investigated by Far-IR Spectroscopy and Molecular Dynamics Simulations.
Cote Y; Nominé Y; Ramirez J; Hellwig P; Stote RH
Biophys J; 2017 Jun; 112(12):2575-2588. PubMed ID: 28636914
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance.
Nicolaides L; Davy C; Raj K; Kranjec C; Banks L; Doorbar J
Virology; 2011 Jun; 414(2):137-45. PubMed ID: 21489588
[TBL] [Abstract][Full Text] [Related]
16. Structural and biochemical analysis of the PTPN4 PDZ domain bound to the C-terminal tail of the human papillomavirus E6 oncoprotein.
Lee HS; Yun HY; Lee EW; Shin HC; Kim SJ; Ku B
J Microbiol; 2022 Apr; 60(4):395-401. PubMed ID: 35089587
[TBL] [Abstract][Full Text] [Related]
17. Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins.
Pim D; Thomas M; Banks L
Oncogene; 2002 Nov; 21(53):8140-8. PubMed ID: 12444549
[TBL] [Abstract][Full Text] [Related]
18. Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6.
Ristriani T; Nominé Y; Masson M; Weiss E; Travé G
J Mol Biol; 2001 Jan; 305(4):729-39. PubMed ID: 11162088
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation.
Thomas M; Laura R; Hepner K; Guccione E; Sawyers C; Lasky L; Banks L
Oncogene; 2002 Aug; 21(33):5088-96. PubMed ID: 12140759
[TBL] [Abstract][Full Text] [Related]
20. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins.
Glaunsinger BA; Lee SS; Thomas M; Banks L; Javier R
Oncogene; 2000 Nov; 19(46):5270-80. PubMed ID: 11077444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
